However, among DNA damage repair genes such as ERCC6, the well-known BRCA gene itself is considered to have no significant effect on the progression of pancreatic cancer, and it seems to show a difference in survival through a difference in responsiveness to platinum-based chemotherapy [37]. This evidence concerns the gene ERCC6 and familial pancreatic carcinoma.